Edwards Lifesciences (EW): analysis and statistics
Return, volatility, Sharpe ratio and risk for Edwards Lifesciences, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $91.78 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +14.23% |
| Total return over period | +48.73% |
| Annualized volatility | 31.34% |
| Period volatility | 54.14% |
| Period T-bill | 12.40% |
| Sharpe ratio | 0.67 |
| Sortino ratio | 0.88 |
| Max drawdown | -37.53% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.72% |
| Correlation with the S&P 500 | 0.29 |
| Period range | $59.70 – $95.56 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Edwards Lifesciences (EW) has posted an annualized return of +14.23% with annual volatility of 31.34%, a Sharpe ratio of 0.67. Its worst stretch (max drawdown from a peak) was -37.53%. Its correlation with the S&P 500 is 0.29, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how EW would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with EW →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Edwards Lifesciences (EW) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio